Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
C4 Therapeutics, Inc. (CCCC) had Cash Flow from Financial Activities of $34.55M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$8.47M |
|
$-21.84M |
|
-- |
|
$8.47M |
|
$33.06M |
|
$-24.60M |
|
$2.75M |
|
$-21.84M |
|
$-21.84M |
|
$-21.84M |
|
$-21.84M |
|
$-21.84M |
|
$-21.84M |
|
$-24.60M |
|
$-24.74M |
|
136.08M |
|
136.08M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$214.50M |
|
$3.83M |
|
$117.30M |
|
$331.80M |
|
$41.46M |
|
-- |
|
$62.17M |
|
$103.63M |
|
$228.17M |
|
$228.17M |
|
$228.17M |
|
131.31M |
|
| Cash Flow Statement Financials | |
$-57.48M |
|
$-19.24M |
|
|
Cash Flow from Financial Activities |
$34.55M |
$78.05M |
|
$35.87M |
|
$-42.18M |
|
$8.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-290.46% |
|
-290.46% |
|
-- |
|
-257.95% |
|
-257.95% |
|
$-57.59M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
6.03 |
|
14.93 |
|
-9.57% |
|
-9.57% |
|
-6.58% |
|
-9.57% |
|
$1.74 |
|
$-0.42 |
|
$-0.42 |
|